Adaptimmune Therapeutics PLC Insider Trading for January 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Adaptimmune Therapeutics PLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Adaptimmune Therapeutics PLC for January 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 28 2020 | ADAP | Adaptimmune Therap ... | MOTT DAVID M | Director | Buy | P | 0.67 | 7,500,000 | 5,000,250 | 19,500,000 | 12 M to 19.5 M (+62.50 %) |
| Jan 28 2020 | ADAP | Adaptimmune Therap ... | Florence Anthony A. Jr. | 10% Owner | Buy | P | 0.67 | 7,500,000 | 5,000,250 | 19,500,000 | 12 M to 19.5 M (+62.50 %) |
| Jan 28 2020 | ADAP | Adaptimmune Therap ... | Behbahani Ali | Director | Buy | P | 0.67 | 7,500,000 | 5,000,250 | 19,500,000 | 12 M to 19.5 M (+62.50 %) |
| Jan 28 2020 | ADAP | Adaptimmune Therap ... | Sonsini Peter W. | 10% Owner | Buy | P | 0.67 | 7,500,000 | 5,000,250 | 19,500,000 | 12 M to 19.5 M (+62.50 %) |
| Jan 28 2020 | ADAP | Adaptimmune Therap ... | BASKETT FOREST | 10% Owner | Buy | P | 0.67 | 7,500,000 | 5,000,250 | 19,500,000 | 12 M to 19.5 M (+62.50 %) |
| Jan 28 2020 | ADAP | Adaptimmune Therap ... | SANDELL SCOTT D | 10% Owner | Buy | P | 0.67 | 7,500,000 | 5,000,250 | 19,500,000 | 12 M to 19.5 M (+62.50 %) |
| Jan 17 2020 | ADAP | Adaptimmune Therap ... | Norry Elliot | Chief Medical Offic ... | Option Exercise | A | 0.00 | 135,600 | 176 | 135,600 | |
| Jan 17 2020 | ADAP | Adaptimmune Therap ... | Norry Elliot | Chief Medical Offic ... | Option Exercise | A | 0.74 | 201,600 | 149,184 | 201,600 | |
| Jan 17 2020 | ADAP | Adaptimmune Therap ... | TAYTON-MARTIN HELEN KATRINA | Chief Business Offi ... | Option Exercise | A | 0.00 | 280,896 | 365 | 280,896 | |
| Jan 17 2020 | ADAP | Adaptimmune Therap ... | TAYTON-MARTIN HELEN KATRINA | Chief Business Offi ... | Option Exercise | A | 0.74 | 1,257,744 | 930,731 | 1,257,744 | |
| Jan 17 2020 | ADAP | Adaptimmune Therap ... | Lunger John | Chief Patient Suppl ... | Option Exercise | A | 0.00 | 280,896 | 365 | 280,896 | |
| Jan 17 2020 | ADAP | Adaptimmune Therap ... | Lunger John | Chief Patient Suppl ... | Option Exercise | A | 0.74 | 1,257,744 | 930,731 | 1,257,744 | |
| Jan 17 2020 | ADAP | Adaptimmune Therap ... | Bertrand William C JR | Chief Operating Off ... | Option Exercise | A | 0.00 | 280,896 | 365 | 280,896 | |
| Jan 17 2020 | ADAP | Adaptimmune Therap ... | Bertrand William C JR | Chief Operating Off ... | Option Exercise | A | 0.74 | 1,257,744 | 930,731 | 1,257,744 | |
| Jan 17 2020 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | Chief Executive Off ... | Option Exercise | A | 0.00 | 561,792 | 730 | 561,792 | |
| Jan 17 2020 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | Chief Executive Off ... | Option Exercise | A | 0.74 | 2,515,536 | 1,861,497 | 2,515,536 | |
| Jan 15 2020 | ADAP | Adaptimmune Therap ... | TAYTON-MARTIN HELEN KATRINA | Chief Business Offi ... | Sell | S | 5.00 | 50,000 | 250,000 | 0 | 50 K to 0 (-100.00 %) |
| Jan 15 2020 | ADAP | Adaptimmune Therap ... | TAYTON-MARTIN HELEN KATRINA | Chief Business Offi ... | Sell | S | 4.00 | 50,000 | 200,000 | 0 | 50 K to 0 (-100.00 %) |
| Jan 15 2020 | ADAP | Adaptimmune Therap ... | Lunger John | Chief Patient Suppl ... | Sell | S | 5.13 | 1,144 | 5,874 | 1,681 | 2.8 K to 1.7 K (-40.50 %) |
| Jan 15 2020 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | Chief Executive Off ... | Sell | S | 5.13 | 3,236 | 16,616 | 3,166 | 6.4 K to 3.2 K (-50.55 %) |
| Jan 15 2020 | ADAP | Adaptimmune Therap ... | Noble James | Director | Sell | S | 5.00 | 200,000 | 1,000,000 | 0 | 200 K to 0 (-100.00 %) |
| Jan 15 2020 | ADAP | Adaptimmune Therap ... | Noble James | Director | Sell | S | 4.00 | 100,000 | 400,000 | 0 | 100 K to 0 (-100.00 %) |
| Jan 15 2020 | ADAP | Adaptimmune Therap ... | Norry Elliot | Chief Medical Offic ... | Sell | S | 5.13 | 911 | 4,678 | 1,326 | 2.2 K to 1.3 K (-40.72 %) |
| Jan 15 2020 | ADAP | Adaptimmune Therap ... | Bertrand William C JR | Chief Operating Off ... | Sell | S | 5.13 | 2,397 | 12,308 | 3,605 | 6 K to 3.6 K (-39.94 %) |
| Jan 15 2020 | ADAP | Adaptimmune Therap ... | Norry Elliot | Chief Medical Offic ... | Sell | S | 5.13 | 911 | 4,678 | 1,326 | 2.2 K to 1.3 K (-40.72 %) |
| Jan 15 2020 | ADAP | Adaptimmune Therap ... | Bertrand William C JR | Chief Operating Off ... | Sell | S | 5.13 | 2,397 | 12,308 | 3,605 | 6 K to 3.6 K (-39.94 %) |
| Jan 07 2020 | ADAP | Adaptimmune Therap ... | Lunger John | Chief Patient Suppl ... | Sell | S | 1.20 | 1,148 | 1,378 | 1,677 | 2.8 K to 1.7 K (-40.64 %) |
| Jan 07 2020 | ADAP | Adaptimmune Therap ... | Bertrand William C JR | Chief Operating Off ... | Sell | S | 1.20 | 3,731 | 4,477 | 5,632 | 9.4 K to 5.6 K (-39.85 %) |
| Jan 07 2020 | ADAP | Adaptimmune Therap ... | Rawcliffe Adrian | Chief Executive Off ... | Sell | S | 1.20 | 5,900 | 7,080 | 5,804 | 11.7 K to 5.8 K (-50.41 %) |